FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3109721891> ?p ?o ?g. }

• W3109721891 abstract "Background: Cancer cachexia is highly prevalent in advanced non-small cell lung cancer (NSCLC) and locally advanced head and neck squamous cell carcinoma (LAHNSCC), and compromises treatment tolerance and overall survival (OS). NSCLC and LAHNSCC patients share similar risk factors, and receive comparable anti-cancer treatment regimens. The aim of this study was to determine the predictive value of body composition assessed by bioelectrical impedance analysis (BIA) and handgrip strength (HGS) (baseline and early changes during therapy) on OS in NSCLC and LAHNSCC patients treated with platinum-based chemoradiotherapy (CRT) or cetuximab-based bioradiotherapy (BRT). To elucidate potential underlying determinants of early changes in body composition and HGS, specific (fat and fat free) mass loss patterns of squamous NSCLC (sNSCLC) were compared to human papilloma virus negative (HPV–) LAHNSCC patients treated with CRT. Methods: Between 2013 and 2016, BIA and HGS were performed at baseline and after 3 weeks of CRT/BRT in LAHNSCC and NSCLC patients treated with curative intent. Results: Two hundred thirty-three patients were included for baseline measurements. Fat free mass index (FFMI) and HGS&lt;10th percentile of reference values at baseline were both prognostic for poor OS in NSCLC and LAHNSCC [HR 1.64 [95%CI 1.13–2.39], p = 0.01 and HR 2.30 [95%CI 1.33–3.97], p = 0.003, respectively], independent of Charlson Comorbidity Index, cancer site, and gross tumor volume. Early fat mass (FM) loss during CRT was predictive for poor OS in sNSCLC ( n = 64) [HR 3.80 [95%CI 1.79–8.06] p ≤ 0.001] but not in HPV– LAHNSCC ( n = 61). In patients with significant weight loss (&gt;2%) in the first 3 weeks of CRT (sNSCLC n = 24, HPV– LAHNSCC n = 23), the FM change was −1.4 ± 14.5% and −8.7 ± 9.0% in sNSCLC and HPV– LAHNSCC patients, respectively ( p &lt; 0.05). Fat fee mass change was −5.6 ± 6.3% and −4.0 ± 4.3% for sNSCLC and HPV– LAHNSCC, respectively ( p = 0.31). Conclusion: FFMI and HGS&lt;10th percentile at baseline are independent prognostic factors for poor OS in NSCLC and LAHNSCC patients treated with CRT/BRT. The specific composition of mass loss during first 3 weeks of CRT significantly differs between sNSCLC and HPV– LAHNSCC patients. Early FM loss was prognostic in sNSCLC only." @default.
• W3109721891 created "2020-12-07" @default.
• W3109721891 creator A5009217884 @default.
• W3109721891 creator A5013504737 @default.
• W3109721891 creator A5013717261 @default.
• W3109721891 creator A5015424682 @default.
• W3109721891 creator A5034998501 @default.
• W3109721891 creator A5047802794 @default.
• W3109721891 creator A5068971778 @default.
• W3109721891 creator A5075812367 @default.
• W3109721891 date "2020-11-26" @default.
• W3109721891 modified "2023-10-14" @default.
• W3109721891 title "Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck" @default.
• W3109721891 cites W1578627958 @default.
• W3109721891 cites W1983667491 @default.
• W3109721891 cites W1985213644 @default.
• W3109721891 cites W2000445173 @default.
• W3109721891 cites W2003282127 @default.
• W3109721891 cites W2008685614 @default.
• W3109721891 cites W2009597511 @default.
• W3109721891 cites W2040644266 @default.
• W3109721891 cites W2040655310 @default.
• W3109721891 cites W2043453187 @default.
• W3109721891 cites W2046107996 @default.
• W3109721891 cites W2051525595 @default.
• W3109721891 cites W2073593203 @default.
• W3109721891 cites W2079650299 @default.
• W3109721891 cites W2083897191 @default.
• W3109721891 cites W2089257078 @default.
• W3109721891 cites W2095699480 @default.
• W3109721891 cites W2104168490 @default.
• W3109721891 cites W2104701073 @default.
• W3109721891 cites W2105969273 @default.
• W3109721891 cites W2110248134 @default.
• W3109721891 cites W2110996227 @default.
• W3109721891 cites W2118558111 @default.
• W3109721891 cites W2134063325 @default.
• W3109721891 cites W2145280166 @default.
• W3109721891 cites W2151730005 @default.
• W3109721891 cites W2152862580 @default.
• W3109721891 cites W2155384808 @default.
• W3109721891 cites W2291298849 @default.
• W3109721891 cites W2510154857 @default.
• W3109721891 cites W2616778044 @default.
• W3109721891 cites W2767101348 @default.
• W3109721891 cites W2773704429 @default.
• W3109721891 cites W2795364709 @default.
• W3109721891 cites W2831700243 @default.
• W3109721891 cites W2890838471 @default.
• W3109721891 cites W2893092082 @default.
• W3109721891 cites W2897798238 @default.
• W3109721891 cites W2904569313 @default.
• W3109721891 cites W2912935316 @default.
• W3109721891 cites W2935312921 @default.
• W3109721891 cites W2941661056 @default.
• W3109721891 cites W2945420558 @default.
• W3109721891 cites W2946496870 @default.
• W3109721891 cites W2957186036 @default.
• W3109721891 cites W2959857170 @default.
• W3109721891 cites W2974792754 @default.
• W3109721891 cites W2980537150 @default.
• W3109721891 cites W2993250474 @default.
• W3109721891 cites W2995942297 @default.
• W3109721891 cites W3006299785 @default.
• W3109721891 cites W3028453792 @default.
• W3109721891 cites W4211243765 @default.
• W3109721891 cites W4249552602 @default.
• W3109721891 cites W4254929655 @default.
• W3109721891 doi "https://doi.org/10.3389/fnut.2020.600612" @default.
• W3109721891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7726186" @default.
• W3109721891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33324671" @default.
• W3109721891 hasPublicationYear "2020" @default.
• W3109721891 type Work @default.
• W3109721891 sameAs 3109721891 @default.
• W3109721891 citedByCount "10" @default.
• W3109721891 countsByYear W31097218912021 @default.
• W3109721891 countsByYear W31097218912022 @default.
• W3109721891 countsByYear W31097218912023 @default.
• W3109721891 crossrefType "journal-article" @default.
• W3109721891 hasAuthorship W3109721891A5009217884 @default.
• W3109721891 hasAuthorship W3109721891A5013504737 @default.
• W3109721891 hasAuthorship W3109721891A5013717261 @default.
• W3109721891 hasAuthorship W3109721891A5015424682 @default.
• W3109721891 hasAuthorship W3109721891A5034998501 @default.
• W3109721891 hasAuthorship W3109721891A5047802794 @default.
• W3109721891 hasAuthorship W3109721891A5068971778 @default.
• W3109721891 hasAuthorship W3109721891A5075812367 @default.
• W3109721891 hasBestOaLocation W31097218911 @default.
• W3109721891 hasConcept C121608353 @default.
• W3109721891 hasConcept C126322002 @default.
• W3109721891 hasConcept C143998085 @default.
• W3109721891 hasConcept C2776214593 @default.
• W3109721891 hasConcept C2776256026 @default.
• W3109721891 hasConcept C2776530083 @default.
• W3109721891 hasConcept C2776833033 @default.
• W3109721891 hasConcept C2777546739 @default.
• W3109721891 hasConcept C2778424827 @default.
• W3109721891 hasConcept C2779998722 @default.
• W3109721891 hasConcept C2780221984 @default.
• W3109721891 hasConcept C33872192 @default.

• next